Half of the data points were inadvertently omitted from the published version of Fig. 4a; the statistical analyses in the text and figure legend, however, do refer to the complete data set. The corrected figure is shown here and has been corrected in the online versions of the paper.In addition, we present additional information to clarify two results reported in the Article regarding plasma pituitary adenylate cyclaseactivating polypeptide (PACAP) levels and post-traumatic stress disorder (PTSD) symptom associations. In the Article, we reported replication of the association between PACAP levels and hyperarousal subscale, because this was the most robust association in the initial cohort. We now present the analyses separately for initial, replication and combined cohorts in Table 1. All associations but one are significant in the replication cohort. The second issue concerns potential medical confounds that could underlie the reported association. Although we do not have medical chart data on most patients, we do have responses from a health questionnaire administered during collection of trauma history and other data. We have now reanalysed the associations for the PTSD symptom scale (PSS) hyperarousal and total symptoms using subjective reports of health condition from the questionnaires as covariates. These data are presented in Table 2 and do not show any effect of health-and illness-related questions on the relationship between PACAP and PTSD symptoms. None of these additions affect the results and conclusions of the original Article.
Carcass characteristics, meat quality traits, and sensory attributes were evaluated in late-finishing barrows and gilts, weighing between 100 to 130 kg of BW, fed 0, 5, or 7.4 mg/kg of ractopamine hydrochloride (RAC) for the final 21 to 28 d before slaughter. Carcass data were collected from carcasses from barrows and gilts (n = 168), and all primal cuts from the right sides of these carcasses were fabricated to calculate primal yields as a percentage of the HCW. Subjective (National Pork Producers Council and Japanese) color, firmness, and marbling scores were determined on the LM of each loin and the semimembranosus muscle (SM) of the ham, whereas the moisture, extractable lipid, Warner-Bratzler shear force (WBSF), and trained sensory evaluations (juiciness, tenderness, and pork flavor) were measured on the LM samples only. Gilts produced heavier (P < 0.05) HCW than barrows, whereas feeding RAC increased (P < 0.05) HCW over pigs fed diets devoid of RAC. Carcasses from gilts also had greater (P < 0.02) primal cut and lean cut (P < 0.01) yields than barrows, and dietary inclusion of 5 mg/kg of RAC increased (P < 0.05) total boneless cut and lean cut yields when compared with carcass from pigs fed 0 or 7.4 mg/kg of RAC. Warner-Bratzler shear forces values were greater (P < 0.05) in the LM of gilts than barrows, but only juiciness scores were greater (P < 0.03) in LM chops from barrows than gilts. The LM from barrows had greater intramuscular lipid (P < 0.001) than the LM from gilts, and even though the LM from pigs fed 5 mg/kg of RAC had greater (P < 0.04) WBSF values than the LM from pigs fed 0 or 7.4 mg/kg of RAC, including RAC in the late-finishing diets for 21 or 28 d did not affect sensory panel rating or percentages of moisture and intramuscular lipid. In summary, addition of RAC in the late-finishing diet improved carcass and primal cut yields when it was fed at 5 and 7.4 mg/kg without altering pork quality traits regardless of whether RAC was fed for 21 or 28 d.
A total of 1,040 growing pigs (initially, 22.9 ± 4.3 kg) were used in a 115-d study to evaluate the effects of 2 mycotoxin mitigation strategies, a preservative blend (PB) and a yeast product (YP), on the growth performance of swine fed diets containing corn dried distillers grains with solubles naturally contaminated with deoxynivalenol (DON). The PB consists of preservatives, antioxidants, AA, and direct-fed microbials and is included in diets to help pigs cope with the toxic effects of ingested mycotoxins. The YP works as an adsorbent to bind and prevent the absorption of mycotoxins in the gastrointestinal tract. Pigs were allotted to pens by initial BW and sex; pens were then assigned to treatments in a randomized block design with initial BW and sex serving as the blocking factors. Pens were randomly allotted to 1 of 4 dietary treatments consisting of a positive control (PC) containing <1 mg kg(-1) DON, a negative control (NC) formulated to contain 4 mg kg(-1) DON, NC with PB, and NC with YP. From d 0 to 42 and 42 to 84, no effect of diets containing PB or YP were observed for any of the growth criteria evaluated. From d 84 to 115, pigs fed PC or diets containing PB had improved (P < 0.05) ADG compared to pigs fed NC or diets containing YP, whereas pigs fed YP had improved (P < 0.05) ADG compared to those fed NC. Pigs fed diets containing PB or YP had improved (P < 0.05) ADFI and G:F compared to pigs fed NC. Overall (d 0 to 115), pigs fed diets containing PB had improved (P < 0.05) ADG, ADFI, and G:F compared to pigs fed NC. These results indicate that PB may be a suitable mycotoxin mitigation strategy in growing swine fed diets naturally contaminated with DON.
Three studies were conducted to compare the effects of 4 different porcine intestinal mucosa products (PEP2, PEP2+, Peptone 50, and PEP-NS; TechMix Inc., Stewart, MN) with select menhaden fish meal (SMFM) on nursery pig performance. These intestine-derived mucosal ingredients are byproducts of heparin production, with a similar amount of mucosal protein, but differ based on the carriers with which they are co-dried. Enzymatically processed vegetable protein is the carrier for PEP2 whereas PEP2+ is co-dried with enzymatically processed vegetable proteins and biomass from crystalline AA production. Peptone 50 uses vegetable protein as its carrier while PEP-NS is co-dried with byproducts of corn wet milling and biomass from crystalline AA production. In Exp. 1, 300 weanling pigs (PIC 327 × 1050; initially 5.4 kg and 19 d of age) were allotted to 1 of 5 dietary treatments with 12 replications and 5 pigs per pen. Diets consisted of a negative control (NC) containing no specialty protein sources, NC with 4, 8, or 12% PEP2 in phases 1 (d 0 to 11) and 2 (d 11 to 25), and a positive control containing 4% spray-dried animal plasma (SDAP) in phase 1 and 4% SMFM in phase 2. From d 0 to 11, pigs fed SDAP had greater (P < 0.05) ADG and G:F than pigs fed PEP2. From d 11 to 25, increasing PEP2 increased (quadratic; P < 0.01) ADG and G:F, with the greatest response observed at 4%. In Exp. 2, 960 weanling pigs (Newsham GPK35 × PIC 380; initially 5.6 kg, and 20 d of age) were allotted to 1 of 5 dietary treatments with 32 pigs per pen and 6 replications per treatment. Diets included a control with 4.5% SDAP in phase 1 (d 0 to 7) and no specialty protein sources in phase 2 (d 7 to 21) or the control diet with 6% of the following: SMFM, PEP2+, Peptone 50, or PEP-NS. From d 0 to 21, pigs fed diets containing SMFM, PEP2+, or PEP-NS had greater (P < 0.05) ADG than pigs fed the control or 6% Peptone 50. In Exp. 3, 180 nursery pigs (PIC 327 × 1050; initially 6.4 kg and 28 d of age) were allotted to 1 of 5 dietary treatments with 5 pigs per pen and 6 replications per treatment. Treatment diets were fed from d 7 to 21 postweaning. Treatments consisted of a NC, NC with 3, 6, 9, or 12% PEP-NS, or NC with 6% SMFM. Overall, pigs fed increasing PEP-NS had improved (quadratic; P < 0.01) ADG and G:F, with the greatest improvement observed in pigs fed 6% PEP-NS, similar to those fed 6% SMFM. These results suggest PEP2, PEP2+, and PEP-NS can effectively replace SMFM in nursery pig diets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.